Literature DB >> 2708846

Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.

L Cantoni1, A Wenger, M P Glauser, J Bille.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2708846     DOI： 10.1093/infdis/159.5.989

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

1.  Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  B Fantin; J Pierre; N Castéla-Papin; L Saint-Julien; H Drugeon; R Farinotti; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

2.  Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.

Authors:  P M Small; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.

Authors:  L Hirano; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

4.  Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.

Authors:  M C Ramos; M Ing; E Kim; M D Witt; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

5.  Efficacy of prophylaxis with beta-lactams and beta-lactam-beta-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model.

Authors:  D S Kernodle; A B Kaiser
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.

Authors:  C Thauvin-Eliopoulos; L B Rice; G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

7.  Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.

Authors:  P Van der Auwera; V Duchateau; C Lambert; M Husson; M Kinzig; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.

Authors:  A Pefanis; C Thauvin-Eliopoulos; G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

9.  Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.

Authors:  Y S Kim; Q Liu; L L Chow; H F Chambers; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

Review 10.  Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.

Authors:  Richard S Slavik; Peter J Jewesson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.